162 related articles for article (PubMed ID: 37271570)
1. Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
Bain BJ; Daniel Y; Henthorn J; de la Salle B; Hogan A; Roy NBA; Mooney C; Langabeer L; Rees DC;
Br J Haematol; 2023 Jun; 201(6):1047-1065. PubMed ID: 37271570
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme.
Griffin M; Eyre J; Dack S; Wright J
J Clin Pathol; 2015 May; 68(5):388-90. PubMed ID: 25694443
[TBL] [Abstract][Full Text] [Related]
3. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7.
Streetly A; Latinovic R; Hall K; Henthorn J
J Clin Pathol; 2009 Jan; 62(1):26-30. PubMed ID: 19103854
[TBL] [Abstract][Full Text] [Related]
4. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
[TBL] [Abstract][Full Text] [Related]
5. Antenatal screening for haemoglobinopathies: current status, barriers and ethics.
Chakravorty S; Dick MC
Br J Haematol; 2019 Nov; 187(4):431-440. PubMed ID: 31509241
[TBL] [Abstract][Full Text] [Related]
6. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
7. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
[TBL] [Abstract][Full Text] [Related]
8. A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders.
Bain BJ; Chapman C
J Clin Pathol; 1998 May; 51(5):382-9. PubMed ID: 9708206
[TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region.
Almeida AM; Henthorn JS; Davies SC
Br J Haematol; 2001 Jan; 112(1):32-5. PubMed ID: 11167779
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017.
Weil LG; Charlton MR; Coppinger C; Daniel Y; Streetly A
J Clin Pathol; 2020 Apr; 73(4):183-190. PubMed ID: 31771971
[TBL] [Abstract][Full Text] [Related]
11. [Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England].
van Rhee MA; Holm JP; Niermeijer MF
Ned Tijdschr Geneeskd; 1998 May; 142(18):996-7. PubMed ID: 9623197
[TBL] [Abstract][Full Text] [Related]
12. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
13. Neonatal haemoglobinopathy screening in Spain.
Mañú Pereira M; Corrons JL
J Clin Pathol; 2009 Jan; 62(1):22-5. PubMed ID: 19103853
[TBL] [Abstract][Full Text] [Related]
14. Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): a 27-year experience.
Saint-Martin C; Romana M; Bibrac A; Brudey K; Tarer V; Divialle-Doumdo L; Petras M; Keclard-Christophe L; Lamothe S; Broquere C; Etienne-Julan M
J Med Screen; 2013 Dec; 20(4):177-82. PubMed ID: 24144845
[TBL] [Abstract][Full Text] [Related]
15. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.
Dormandy E; Bryan S; Gulliford MC; Roberts TE; Ades AE; Calnan M; Atkin K; Karnon J; Barton PM; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Davis V; Brown K; Juarez-Garcia A; Tsianakas V; Marteau TM
Health Technol Assess; 2010 Apr; 14(20):1-160. PubMed ID: 20416236
[TBL] [Abstract][Full Text] [Related]
16. Newborn bloodspot results: predictive value of screen positive test for thalassaemia major.
Streetly A; Latinovic R; Henthorn J; Daniel Y; Dormandy E; Darbyshire P; Mantio D; Fraser L; Farrar L; Will A; Tetlow L
J Med Screen; 2013 Dec; 20(4):183-7. PubMed ID: 24277229
[TBL] [Abstract][Full Text] [Related]
17. Neonatal haemoglobinopathy screening in Belgium.
Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
[TBL] [Abstract][Full Text] [Related]
18. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
19. Starting neonatal screening for haemoglobinopathies in The Netherlands.
Giordano PC
J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
[TBL] [Abstract][Full Text] [Related]
20. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
